Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Reviva Pharmaceuticals Holdings (RVPH) Purchase of Investments (2019 - 2020)

Updated

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Purchase of Investments (2019 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 258.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 919.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 300.00 Mn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 4.40 Bn
10 Reviva Pharmaceuticals Holdings 4.46 Mn -82.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2020 105,083.00
Aug 31, 2020 421,005.00
May 31, 2020 210,836.00
Feb 29, 2020 -169,742.00
Feb 28, 2019 64.52 Mn
API Access

Reviva Pharmaceuticals Holdings Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=RVPH&period=max&api_key=YOUR_API_KEY